HWA
TEVA icon

Heritage Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Heritage Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-150
Closed -$1K – 560
2021
Q4 		$1K Hold
150
– – ﹤0.01% 532
2021
Q3 		$1.46K Hold
150
– – ﹤0.01% 507
2021
Q2 		$1.49K Buy
+150
New +$1.59K ﹤0.01% 517
2019
Q3 		– Sell
-10
Closed -$92 – 467
2019
Q2 		$92 Sell
10
-130
-93% -$1.57K ﹤0.01% 445
2019
Q1 		$2.19K Hold
140
– – ﹤0.01% 409
2018
Q4 		$2K Hold
140
– – ﹤0.01% 365
2018
Q3 		$3K Buy
+140
New +$3.25K ﹤0.01% 347

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Heritage Wealth Advisors's TEVA Position: Q1 2022 in Review

Heritage Wealth Advisors sold out of Teva Pharmaceuticals (TEVA) in Q1 2022, closing a stake of 150 shares — an estimated $1K sold.

Heritage Wealth Advisors first reported a position in TEVA in Q3 2018 and held it in 7 quarters. The position peaked at $3K in Q3 2018. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2022.

  • Heritage Wealth Advisors reported no remaining Teva Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Heritage Wealth Advisors sold 150 Teva Pharmaceuticals shares in Q1 2022, an estimated $1K.
  • Heritage Wealth Advisors first reported a position in Teva Pharmaceuticals in Q3 2018 and held it in 7 quarters.
  • Heritage Wealth Advisors's Teva Pharmaceuticals position peaked at $3K in Q3 2018.
  • 438 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2022.

Based on Heritage Wealth Advisors's 13F filing for Q1 2022, filed 11 May 2022.